11:54 AM EST - ProMetic Life Sciences : Announced that Telesta Therapeutics Inc. has executed a binding Agreement, subject to shareholder approval, to be acquired by ProMetic Life Sciences Inc. for consideration of $0.14/Telesta share, payable in freely tradable shares of ProMetic Life Sciences, ProMetic Life Sciences
shares T.PLI are trading up $0.16 at $2.99.
